TNGX
Tango Therapeutics Inc
23.80$
+5.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | |
| 229.7% | 219.8% | – | 4.7% | 7.0% | 2.5% | 323.0% | 10.1% | 11.6% | 11.9% | 17.6% | 22.6% | 25.3% | 10.3% | 5.7% | 11.4% | 9.7% | 3.2% | – | 15.1% | – | 19.6% | 1.0% | – | – | – | – | |
| -129.7% | -119.8% | – | 95.3% | 93.0% | 97.5% | -223.0% | 89.9% | 88.4% | 88.1% | 82.4% | 77.4% | 74.7% | 89.7% | 94.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 80.4% | 100.0% | – | – | – | – | |
| 229.7% | 219.8% | – | 164.8% | 234.9% | 105.1% | 323.0% | 378.5% | 422.5% | 411.4% | 415.4% | 453.8% | 486.3% | 196.4% | 253.0% | 577.0% | 588.2% | 194.5% | 286.6% | 824.3% | 675.9% | 1,011.7% | 57.3% | – | – | – | 249.7% | |
| 41.5% | 47.0% | – | 33.0% | 54.3% | 20.0% | 65.3% | 106.1% | 118.2% | 125.3% | 117.0% | 123.0% | 139.0% | 62.8% | 85.8% | 167.6% | 164.8% | 54.2% | 96.7% | 269.4% | 212.9% | 356.5% | 16.6% | – | – | – | 105.0% | |
| 41.5% | 47.0% | – | 193.1% | 282.2% | 122.6% | 65.3% | 474.5% | 529.1% | 524.8% | 514.8% | 554.1% | 600.0% | 248.9% | 333.1% | 744.7% | 753.0% | 248.7% | 383.3% | 1,093.7% | 888.8% | 1,368.2% | 73.8% | – | – | – | 351.6% | |
| -171.2% | -166.7% | – | -97.8% | -189.2% | -25.1% | -288.3% | -384.6% | -440.8% | -436.7% | -432.4% | -476.8% | -525.3% | -159.2% | -238.8% | -644.7% | -653.0% | -148.7% | -283.3% | -993.7% | -788.8% | -1,287.9% | 26.2% | – | – | – | -253.4% | |
| – | – | – | – | – | – | 1.3% | 10.2% | 3.8% | 5.1% | 5.1% | 32.4% | 10.1% | – | – | 10.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -168.0% | -165.7% | – | -97.0% | -188.4% | -24.9% | -287.7% | -382.6% | -437.8% | -430.7% | -419.8% | -452.5% | -485.7% | -141.4% | -207.2% | -565.6% | -585.3% | -128.2% | -250.8% | -913.8% | -738.9% | -1,220.3% | 29.5% | – | – | – | -230.0% | |
| – | – | – | 0.0% | 1.2% | -0.1% | 0.9% | 3.1% | -3.0% | 0.1% | -12.6% | 0.8% | -39.5% | 0.4% | 0.2% | 0.9% | 0.6% | 0.3% | 0.5% | 1.2% | 0.6% | 1.1% | 0.0% | – | – | – | -0.1% | |
| -168.0% | -165.7% | – | -97.0% | -189.6% | -24.8% | -288.6% | -385.7% | -437.8% | -430.7% | -419.8% | -453.3% | -485.7% | -141.9% | -207.4% | -566.4% | -585.9% | -128.6% | -251.3% | -915.0% | -739.5% | -1,221.4% | 29.5% | – | – | – | -229.9% | |
| -167.7% | -163.2% | – | -92.3% | -181.4% | -22.3% | -284.4% | -372.5% | -426.2% | -418.8% | -402.2% | -429.8% | -460.5% | -131.1% | -201.5% | -554.2% | -575.6% | -125.1% | -245.5% | -898.7% | -727.4% | -1,200.7% | 30.5% | – | – | – | -227.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.